Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer

被引：0
|
作者：
Govindan, R. [1 ]
Fakih, M. [2 ]
Price, T. [3 ]
Falchook, G. [4 ]
Desai, J. [5 ]
Kuo, J. [6 ]
Strickler, J. [7 ]
Krauss, J. [8 ]
Li, B. [9 ]
Denlinger, C. [10 ]
Durm, G. [11 ]
Ngang, J. [12 ]
Henary, H. [12 ]
Ngarmchamnanrith, G. [12 ]
Rasmussen, E. [12 ]
Morrow, P. K. [12 ]
Hong, D. [13 ]
机构：
[1] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Queen Elizabeth Hosp, Woodville South, Australia
[4] HealthONE, Sarah Cannon Res Inst, Denver, CO USA
[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[6] Scientia Clin Res, Randwick, NSW, Australia
[7] Duke Univ, Med Ctr, Durham, NC 27706 USA
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[10] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[11] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[12] Amgen Inc, Thousand Oaks, CA 91320 USA
[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
AMG; 510; lung cancer; KRAS G12C; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA01.06
引用
收藏
页码：S1125 / S1126
页数：2
相关论文
共 50 条
  • [21] The efficacy and safety of lcotinib in patients with advanced non-small cell lung cancer: compare with gefitinib
    Zhang, Zhe
    Wang, Qiming
    Tang, Hong
    Xia, Suhua
    He, Zelai
    He, Zhen
    Wang, Lili
    Zhu, Hui
    Li, Shaomei
    Wu, Yufeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 18360 - 18366
  • [22] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [23] Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
    Velez, Michel
    Arango, Belisario A.
    Perez, Cesar A.
    Santos, Edgardo S.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 117 - 124
  • [24] Safety and Efficacy of Lattice Radiotherapy in Voluminous Non-small Cell Lung Cancer
    Amendola, Beatriz E.
    Perez, Naipy C.
    Wu, Xiaodong
    Amendola, Marco A.
    Qureshi, Ian Z.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [25] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [26] Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer
    Hida, Toyoaki
    Nishio, Makoto
    Nogami, Naoyuki
    Ohe, Yuichiro
    Nokihara, Hiroshi
    Sakai, Hiroshi
    Satouchi, Miyako
    Nakagawa, Kazuhiko
    Takenoyama, Mitsuhiro
    Isobe, Hiroshi
    Fujita, Shiro
    Tanaka, Hiroshi
    Minato, Koichi
    Takahashi, Toshiaki
    Maemondo, Makoto
    Takeda, Koji
    Saka, Hideo
    Goto, Koichi
    Atagi, Shinji
    Hirashima, Tomonori
    Sumiyoshi, Naoki
    Tamura, Tomohide
    CANCER SCIENCE, 2017, 108 (05) : 1000 - 1006
  • [27] Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
    Jiang, Fenge
    Li, Junxia
    Kong, Xiangshuo
    Sun, Ping
    Qu, Huajun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection
    Pertejo-Fernandez, Ana
    Ricciuti, Biagio
    Hammond, Sarah P.
    Marty, Francisco M.
    Recondo, Gonzalo
    Rangachari, Deepa
    Costa, Daniel B.
    Awad, Mark M.
    LUNG CANCER, 2020, 145 : 181 - 185
  • [29] Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
    Khan, Husain Yar
    Nagasaka, Misako
    Aboukameel, Amro
    Alkhalili, Osama
    Uddin, Md. Hafiz
    Bannoura, Sahar F.
    Mzannar, Yousef
    Azar, Ibrahim
    Beal, Eliza W.
    Tobon, Miguel E.
    Kim, Steve H.
    Beydoun, Rafic
    Baloglu, Erkan
    Senapedis, William
    El-Rayes, Bassel F.
    Philip, Philip A.
    Mohammad, Ramzi M.
    Shields, Anthony F.
    Al Hallak, Mohammed Najeeb
    Azmi, Asfar S.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12) : 1422 - 1433
  • [30] Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non-small cell lung cancer
    Kanai, Osamu
    Ito, Takanori
    Saito, Zentaro
    Yamamoto, Yuki
    Fujita, Kohei
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    THORACIC CANCER, 2021, 12 (06) : 949 - 957
12345